Evidence map›Paper›PMID 39379090›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2024

Hearing loss in patients with dementia in Saudi Arabia.

Laila Alqahtani, Lena Alotaibi, Jullanar Alkhunein, Reema Alduaiji, Reema Alqadiri, Fawaz Alibrahim, Salih binSalih, Hashim Balubaid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laila AlqahtaniFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.ORCID https://orcid.org/0009-0003-5023-6003
Lena AlotaibiFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Jullanar AlkhuneinFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Reema AlduaijiFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Reema AlqadiriFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Fawaz AlibrahimFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Salih binSalihFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Hashim BalubaidFrom the College of Medicine (Alqahtani, Alkhunein, alduaiji, Alqadiri), King Abdullah International Medical Research Center (Alqahtani, Alotaibi, Alkhunein, alduaiji, Alqadiri, Alibrahim, binSalih, Balubaid), Department of Medicine (binSalih, Balubaid), Division of Neurology (Alibrahim), Department of Medicine King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Riyadh, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the prevalence of hearing loss in patients with dementia, examine the use of hearing aids in those with hearing loss, and ascertain if the cause of hearing loss is central or peripheral in origin.

methodsA retrospective cohort study involving 143 patients with dementia which was conducted in Saudi Arabia from 2020 to 2023 in King Abdulaziz Medical City, Riyadh, Saudi Arabia, to determine hearing loss. The study included patients aged ≥60 years who had dementia, hearing loss, and neurological diseases. Those with Parkinson's disease and secondary epilepsy were excluded. Data was analyzed for its demographics, clinical features, predisposing factors, treatment, dementia duration and progression, and hearing loss outcomes. All statistical analyses were performed using IBM's SPSS software, version 29.0.0. Statistical significance was established at a

resultsThe findings indicated that 88.8% of the 143 patients exhibited dementia, with Alzheimer's disease being the most prevalent type. Moreover, 18.2% had hearing issues, and 11.2% had other complaints. Audiometry was performed in 15.4% of the cases. Hearing loss was present in 14.7% of the patients, being primarily bilateral, ranging from mild to severe.

conclusionThis study has clarified the link between hearing loss and dementia onset and has emphasized the need for early evaluation and intervention for individuals with hearing impairment.

Indexed as

DementiaHearing LossAgedAged, 80 and overCohort StudiesFemaleHearing AidsHumansMaleMiddle AgedPrevalenceRetrospective StudiesSaudi Arabia

Identifiers

PMID39379090
PMCPMC11460783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.